Verily Life Sciences
A life sciences arm of Google-parent company Alphabet that develops tools and devices to collect, organize and activate health data, and creates
interventions to prevent and manage disease.
Launched in 2015, Verily is a subsidiary of Alphabet focused on life sciences and healthcare.
Verily partners with leading life sciences, medical device and government organizations, using hardware, software, scientific, and healthcare expertise to enable faster development, advances, and deployment at scale.
In May 2019, the company has announced partnership with Novartis, Otsuka Pharmaceutical, Pfizer and Sanofi in a project that aims to engage patients and clinicians in research and speed evidence generation.
Latest Verily Life Sciences News & Features
7 January 2022
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze